The first stage of a renewed federal ban on hemp products took effect in the United States on Thursday 12 November 2026. It is no longer federally legal to produce or sell hemp products containing cannabinoids that cannot be naturally produced by the cannabis plant, as first reported by Marijuana Moment.

A broader ban on hemp products containing THC is scheduled for 11 December. Industry groups and a bipartisan group of lawmakers, working with the Trump administration, are pushing Congress to pass regulation instead. It is not yet clear whether any such proposal can pass both chambers and reach the president in time.

How the ban came about

Hemp derivatives with less than 0.3 per cent delta-9 THC on a dry-weight basis were legalised federally by the 2018 Farm Bill, signed by Donald Trump in his first term. Late last year he signed new legislation that redefined hemp, so that only products with 0.4 milligrams of total THC per container would stay legal after 12 November.

A separate funding bill signed this September pushed the effective date for most products back to 11 December, to give lawmakers more time to draft rules. It kept 12 November for synthetic cannabinoids “that are not capable of being naturally produced by a Cannabis sativa L. plant”. The restriction covers both intermediate and final hemp-derived products.

There is disagreement over which products on the market are affected. The first phase does not cover converting cannabinoids that the plant can produce naturally, for example turning CBD into delta-9 THC, delta-8 THC or related isomers.

Industry reaction

Jonathan Miller, general counsel for the U.S. Hemp Roundtable, said the industry had “long called for the banning of synthetic cannabinoids” and supported this step. He said the group hoped Congress would soon pass a plan to regulate hemp-derived products rather than the “ill advised complete ban” due on 11 December.

Jim Higdon of Cornbread Hemp said synthetic cannabinoids such as HHC “had no business in the legitimate hemp industry to begin with”.

HHC, however, occurs in trace amounts in the cannabis plant, according to a 2023 study in Current Neuropharmacology and a 2024 study in Scientific Reports. Some therefore believe it is not removed from the legal definition of hemp in this first phase, even when made by chemical conversion, because the compound itself can be naturally produced by the plant.

The American Trade Association for Cannabis and Hemp, which represents state-licensed marijuana businesses, argued that few products now on sale will be affected. It noted that the Food and Drug Administration is more than nine months late in publishing a legally required list of known cannabinoids and guidance on hemp product containers. The group said the list, once issued, “will settle the edges of this category”.

Bills in Congress

Lawmakers from both parties and both chambers have introduced or are circulating bills to stop the wider ban. Representatives Beth Van Duyne and Greg Landsman proposed keeping hemp THC drinks legal while taxing and regulating them like alcohol. Representative James Comer is circulating legislation to delay the ban and add packaging, testing and age rules. Representative Andy Barr has filed a longer proposal with an age limit of 21, and Representatives Morgan Griffith and Marc Veasey have put forward a measure allowing sales to adults over 21.

Senators Tim Sheehy and Amy Klobuchar are expected to file their own proposal soon. Advocates hope to attach one to must-pass legislation before 11 December.

At state level, a Missouri hemp restriction law also took effect on Thursday, while a similar law in Illinois is on hold amid litigation.

Why it matters in the UK

The US is a major market for hemp-derived products, and its rules are watched by the wider industry. In the UK, CBD products can be sold subject to the Food Standards Agency’s novel food rules and strict limits on controlled cannabinoids such as THC, and cannabis remains a Class B drug under the Misuse of Drugs Act 1971.